SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products Due to Potential Contamination

PUBLISHED: Oct 23, 2017
Relevant to: Ambulatory Care, Critical Access Hospitals, Hospitals, Pharmacies

SCA Pharmaceuticals LLC is voluntarily recalling multiple injectable products to the hospital level. See the recall notice, link below, for a complete listing of all recalled products. There is potential for the products to contain microbial contamination.

Administration of a drug product, intended to be sterile, that may contain microbial contamination has the potential to result in serious adverse events which may include life-threatening infections. SCA Pharmaceuticals has not received any customer complaints or reports of adverse events related to this issue, but out of an abundance of caution, is voluntarily initiating this recall.

SCA Pharmaceuticals is notifying its customers via telephone, email and US mail and is arranging for return/replacement of all recalled products. Customers that have product which is being recalled, as indicated in the list above, should discontinue use immediately and return the product to SCA Pharmaceuticals.

See the recall notice for additional information.

Want to read the full alert and receive alert emails?

Browse Additional Alerts